One-Year study aims to uncover triggers of psychosis relapse in meth users

NCT ID NCT07459257

Recruiting now Knowledge-focused Sponsor: Elazığ Mental Health and Diseases Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows 150 people diagnosed with methamphetamine-induced psychotic disorder for one year. Researchers will track factors like medication adherence, social support, and insight into illness to see how they relate to changes in psychiatric symptoms. The goal is to better understand why some people relapse and others recover, which could improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify key factors that predict relapse or recovery in methamphetamine-induced psychosis, helping doctors tailor support and treatment.
What could go wrong: This is an observational study, not a treatment trial, so it won't test a new therapy. Results may not apply to all patients, and factors like adherence or social support can be hard to measure accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE INDUCED PSYCHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

methamphetamine-induced psychosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METHAMPHETAMINE INDUCED PSYCHOSIS

Contacts and locations

Locations

Elazığ Mental Health and Diseases Hospital
RECRUITING

Elâzığ, Elâzığ, 23200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.